Transcranial direct current stimulation provided no additional benefit when added to antidepressant therapy for adults with major depressive disorder in a controlled trial.
TORONTO COVID-19 hasn’t just worsened mental health across the country it’s also cut access to specific medical treatments for those who struggle from severe depression, such as electroconvulsive therapy (ECT). But the pressure of a pandemic has also spurred scientists to focus on some new therapies in order to keep helping patients, turning necessity into opportunity. One patient who underwent an experimental therapy during the pandemic believes it could change lives, and even replace ECT altogether. Kileen Sprock was in need of urgent help a month ago when she turned to a new treatment. The human resources specialist had struggled with depression on and off for the past five years, undergoing various treatment.